Evaluation of the Efficacy in Decreasing Myopia Progression of the Proposed Ophthalmic Lens Prototypes

NCT05250206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2025-06-10

Study results available
· View outcomes & findings →

Summary

Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.

Conditions

  • Myopia

Interventions

OTHER

Myopia control lens

Evaluation of the efficacy in decreasing myopia progression of the proposed ophthalmic lens prototypes.

Sponsors & Collaborators

  • Universidad Europea de Madrid

    collaborator OTHER
  • Indizen Optical Technologies, S.L.U.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-07
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05250206 on ClinicalTrials.gov